Literature DB >> 21589992

Transcriptional regulation by miRNA mimics that target sequences downstream of gene termini.

Scott T Younger1, David R Corey.   

Abstract

Transcriptome studies have revealed that protein-coding loci within the human genome are overlapped at their 3'-termini by noncoding RNA (ncRNA) transcripts. Small duplex RNAs designed to be fully complementary to these 3' ncRNAs can modulate transcription of the upstream gene. Robust regulation by designed RNAs suggests that endogenous small RNAs might also recognize 3' ncRNAs and regulate gene expression. A genome-wide evaluation revealed that sequences immediately downstream of protein-coding genes are enriched with miRNA target sites. We experimentally tested miRNA mimics complementary to the well-characterized 3'-terminus of the human progesterone receptor (PR) gene and observed inhibition of PR transcription. These results suggest that recognition of ncRNA transcripts that overlap gene termini may be a natural function of endogenous small RNAs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21589992      PMCID: PMC4668949          DOI: 10.1039/c1mb05090g

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  36 in total

Review 1.  Natural antisense and noncoding RNA transcripts as potential drug targets.

Authors:  Claes Wahlestedt
Journal:  Drug Discov Today       Date:  2006-06       Impact factor: 7.851

2.  The evolution of our thinking about microRNAs.

Authors:  Victor Ambros
Journal:  Nat Med       Date:  2008-10       Impact factor: 53.440

3.  MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer.

Authors:  Shahana Majid; Altaf A Dar; Sharanjot Saini; Soichiro Yamamura; Hiroshi Hirata; Yuichiro Tanaka; Guoren Deng; Rajvir Dahiya
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

4.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

5.  Effect of chemical modifications on modulation of gene expression by duplex antigene RNAs that are complementary to non-coding transcripts at gene promoters.

Authors:  Jonathan K Watts; Dongbo Yu; Klaus Charisse; Christophe Montaillier; Pierre Potier; Muthiah Manoharan; David R Corey
Journal:  Nucleic Acids Res       Date:  2010-04-19       Impact factor: 16.971

6.  Predicting potential miRNA target sites within gene promoters.

Authors:  Scott T Younger; Alexander Pertsemlidis; David R Corey
Journal:  Bioorg Med Chem Lett       Date:  2009-04-18       Impact factor: 2.823

7.  The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus.

Authors:  C J Brown; B D Hendrich; J L Rupert; R G Lafrenière; Y Xing; J Lawrence; H F Willard
Journal:  Cell       Date:  1992-10-30       Impact factor: 41.582

8.  PcG proteins, DNA methylation, and gene repression by chromatin looping.

Authors:  Vijay K Tiwari; Kelly M McGarvey; Julien D F Licchesi; Joyce E Ohm; James G Herman; Dirk Schübeler; Stephen B Baylin
Journal:  PLoS Biol       Date:  2008-12-02       Impact factor: 8.029

9.  Identification and classification of conserved RNA secondary structures in the human genome.

Authors:  Jakob Skou Pedersen; Gill Bejerano; Adam Siepel; Kate Rosenbloom; Kerstin Lindblad-Toh; Eric S Lander; Jim Kent; Webb Miller; David Haussler
Journal:  PLoS Comput Biol       Date:  2006-04-21       Impact factor: 4.475

10.  Antisense transcripts are targets for activating small RNAs.

Authors:  Jacob C Schwartz; Scott T Younger; Ngoc-Bich Nguyen; Daniel B Hardy; Brett P Monia; David R Corey; Bethany A Janowski
Journal:  Nat Struct Mol Biol       Date:  2008-07-06       Impact factor: 15.369

View more
  14 in total

Review 1.  Argonaute and the nuclear RNAs: new pathways for RNA-mediated control of gene expression.

Authors:  Keith T Gagnon; David R Corey
Journal:  Nucleic Acid Ther       Date:  2012-01-27       Impact factor: 5.486

Review 2.  Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.

Authors:  Catalina Méndez; Chantelle L Ahlenstiel; Anthony D Kelleher
Journal:  World J Virol       Date:  2015-08-12

3.  Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas.

Authors:  Edward A Ratovitski
Journal:  Cell Cycle       Date:  2014-01-06       Impact factor: 4.534

Review 4.  Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression.

Authors:  Mengfan Pu; Jing Chen; Zhouteng Tao; Lingling Miao; Xinming Qi; Yizheng Wang; Jin Ren
Journal:  Cell Mol Life Sci       Date:  2018-10-29       Impact factor: 9.261

5.  Transcriptional targeting by microRNA-polycomb complexes: a novel route in cell fate determination.

Authors:  Giuseppe Zardo; Alberto Ciolfi; Laura Vian; Monia Billi; Serena Racanicchi; Francesco Grignani; Clara Nervi
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

Review 6.  miRNA goes nuclear.

Authors:  Vera Huang; Long-Cheng Li
Journal:  RNA Biol       Date:  2012-03-01       Impact factor: 4.652

7.  Upregulation of Cyclin B1 by miRNA and its implications in cancer.

Authors:  Vera Huang; Robert F Place; Victoria Portnoy; Ji Wang; Zhongxia Qi; Zhejun Jia; Angela Yu; Marc Shuman; Jingwei Yu; Long-Cheng Li
Journal:  Nucleic Acids Res       Date:  2011-11-03       Impact factor: 16.971

8.  Progesterone: a universal stimulus for neuronal cells?

Authors:  Verena Theis; Carsten Theiss
Journal:  Neural Regen Res       Date:  2015-04       Impact factor: 5.135

9.  Tumor Protein p63/microRNA Network in Epithelial Cancer Cells.

Authors:  Edward A Ratovitski
Journal:  Curr Genomics       Date:  2013-11       Impact factor: 2.236

10.  The MicroRNA Biology of the Mammalian Nucleus.

Authors:  Thomas C Roberts
Journal:  Mol Ther Nucleic Acids       Date:  2014-08-19       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.